Icon

AUGMENTIN XR (nda050785)- (1GM;EQ 62.5MG BASE)

AMOXICILLIN; CLAVULANATE POTASSIUM US ANTIBIOTICS
1GM;EQ 62.5MG BASE
Yes No
2020-Apr-04 Expired
None None
None No
Augmentin XR Extended Release Tablets are indicated for the treatment of patients with communityacquired pneumonia or acute bacterial sinusitis due to confirmed, or suspected β-lactamase-producing pathogens (i.e., H. influenzae, M. catarrhalis, H. parainfluenzae, K. pneumoniae, or methicillinsusceptible S. aureus) and S. pneumoniae with reduced susceptibility to penicillin (i.e., penicillin MICs = 2 μg/mL).
1 0 1
Total Other Developers 1
Drugs with Suitability No
1GM;EQ 62.5MG BASE ** ** - - 1
NDA Sales Available Total Generic Sales Available
No 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.